As of Jan 17, 2025, Apple Relative Value is $113.8. This suggests it may be overvalued by 16.2% compared to its current price of around $97.9.
As of Jan 17, 2025, Merck & Co., Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at N/A. This suggests it may be overvalued by N/A to its current price of around $97.9, using a discount rate of 6.9% and terminal growth rate of 3.0%.
As of Jan 17, 2025, Apple Intrinsic Value is $113.7. This suggests it may be undervalued by 16.1% compared to its current price of around $97.9.